I agree that this site is using cookies. You can find further informations here.
X
Denham, Douglas
56  results:
Search for persons X
?
1

Immunogenicity, efficacy, and safety of biosimilar insulin ..:

Christofides, Elena A. ; Puente, Orlando ; Norwood, Paul...
Diabetes, Obesity and Metabolism.  26 (2024)  6 - p. 2412-2421 , 2024
Link: https://doi.org/10.1111/..
 
?
2

Immunogenicity, Efficacy, and Safety of Biosimilar Insulin ..:

Christofides, Elena A. ; Stankiewicz, Andrzej ; Denham, Douglas...
Endocrine Practice.  , 2024
Link: https://doi.org/10.1016/..
 
?
3

Long-Term Safety and Efficacy of Recombinant Human Parathyr..:

Watts, Nelson B ; Bilezikian, John P ; Bone, Henry G...
Journal of the Endocrine Society.  7 (2023)  5 - p. , 2023
Link: https://doi.org/10.1210/..
 
?
4

EDP-305 in patients with NASH: A phase II double-blind plac..:

Ratziu, Vlad ; Rinella, Mary E. ; Neuschwander-Tetri, Brent A....
Journal of Hepatology.  76 (2022)  3 - p. 506-517 , 2022
Link: https://doi.org/10.1016/..
 
?
5

TERN-101, a farnesoid X receptor agonist, demonstrated simi..:

Lawitz, Eric ; Loomba, Rohit ; Denham, Douglas...
Journal of Hepatology.  77 (2022)  - p. S715-S716 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Favorable safety profile of TERN-201, a highly selective in..:

Noureddin, Mazen ; Lawitz, Eric ; Alkhouri, Naim...
Journal of Hepatology.  77 (2022)  - p. S731-S732 , 2022
Link: https://doi.org/10.1016/..
 
?
7

A Head-to-Head Comparison Study of the First-Day Performanc..:

Denham, Douglas
Journal of Diabetes Science and Technology.  14 (2020)  2 - p. 493-495 , 2020
Link: https://doi.org/10.1177/..
 
?
8

Effect of Repeated Doses of Acetaminophen on a Continuous G..:

Denham, Douglas
Journal of Diabetes Science and Technology.  15 (2020)  2 - p. 517-518 , 2020
Link: https://doi.org/10.1177/..
 
?
9

EDP-305, a non-bile acid farnesoid X receptor (FXR) agonist..:

Ratziu, Vlad ; Rinella, Mary ; Tetri, Brent...
Journal of Hepatology.  73 (2020)  - p. S56-S57 , 2020
Link: https://doi.org/10.1016/..
 
?
10

Safety and Efficacy of 5 Years of Treatment With Recombinan..:

Mannstadt, Michael ; Clarke, Bart L ; Bilezikian, John P...
The Journal of Clinical Endocrinology & Metabolism.  104 (2019)  11 - p. 5136-5147 , 2019
Link: https://doi.org/10.1210/..
 
?
11

OR30-1 Safety and Efficacy of Recombinant Human Parathyroid..:

Bilezikian, John ; Bone, Henry ; Clarke, Bart...
Journal of the Endocrine Society.  3 (2019)  Supplement_1 - p. , 2019
Link: https://doi.org/10.1210/..
 
?
12

Publisher Correction: Glucagon receptor antagonist volagide..:

Pettus, Jeremy ; Boeder, Schafer C. ; Christiansen, Mark P....
Nature Medicine.  29 (2023)  11 - p. 2959-2959 , 2023
Link: https://doi.org/10.1038/..
 
?
13

Glucagon receptor antagonist volagidemab in type 1 diabetes..:

Pettus, Jeremy ; Boeder, Schafer C. ; Christiansen, Mark P....
Nature Medicine.  28 (2022)  10 - p. 2092-2099 , 2022
Link: https://doi.org/10.1038/..
 
?
14

Glycemic Effect and Safety of a Systemic, Partial Glucokina..:

Denney, William S. ; Denham, Douglas S. ; Riggs, Michael R..
Clinical Pharmacology in Drug Development.  5 (2016)  6 - p. 517-527 , 2016
Link: https://doi.org/10.1002/..
 
?
15

Metanx in Type 2 Diabetes with Peripheral Neuropathy: A Ran..:

Fonseca, Vivian A. ; Lavery, Lawrence A. ; Thethi, Tina K....
The American Journal of Medicine.  126 (2013)  2 - p. 141-149 , 2013
Link: https://doi.org/10.1016/..
 
1-15